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Best-Estimate Low-Dose Extrapolation
of Carcinogenicity Data
by H. A. Guess* and K. S. Crump*
At the 1974 NIEHS conference on low-dose ex-
trapolation, Peto (1) reported that evidence con-
cerningchronic exposure to direct carcinogens (i.e.,
those acting on the DNA, producing mutations)
suggests that the excess rate of incidence over
background should be given by the product of a
function ofthe dose and a function ofthe exposure
duration. The function of the dose should be a
plynomial of the form
qldl + q2d2 + ... + qKdK
with qi
- 0 and q, > 0. Expressions ofthis form for
the excess rate of incidence over background cor-
respond to lifetime response probabilities of the
form
P(d) = 1 - exp {-(qo + qldl + * + qKdK)}
qi
- 0(1)
We have developed a low-dose extrapolation
technique for dichotomous data, using an assumed
dose-response relation of the form (1) but without
making any assumptions about whether the coeffi-
cient of the linear term is positive or about the de-
gree ofthe polynomial. We use maximum likelihood
to determine both the degree K of the polynomial
and the coefficients qi > 0, for 0
- i
- K. Al-
lowance for nonzero background is made automat-
ically by fitting the constant term, q0. Our estimate
of the increased response probability over
background is given by
P(d) - P(O) = e-qo [1 - exp {- (q,d' +
.. . + qKdK)}] (2)
At very low doses this looks like
P(d)- P() = e-£O q4dl (3)
*Environmental Biometry Branch, National Institute of En-
vironmental Health Sciences, Box 12233, Research Triangle
Park, N. C. 27709.
for d « 1, where I is the smallest positive integer
for which q1 > 0. At high doses, the shape of the
curve is governed by the highest-order coefficient,
qK.
Unlike previous dose-response models, which
contain only one or two free parameters to be de-
termined, this model contains infinitely many, be-
cause the degree of the polynomial is left to be de-
termined by the data. For any given set of data,
only finitely many coefficients will be nonzero;
however we do not make any a priori assumptions
about which coefficients will nonzero. In view of
Eq. (3), the resulting low-dose extrapolation will
look like thatofan1-hit model for someI = 1,2, . .
depending on the data.
By considering at once all polynomials with non-
negative coefficients-unrestricted as to degree
we are able to compare dose-response curves that
are linear in the low-dose range with dose-response
curves that are extremely flat in the low-dose range.
Foreach setofdata we calculate the (in most cases)
uniquely determined set ofnonnegative coefficients
which best fits the data, in the sense of maximizing
the likelihood function over the class of all polyno-
mials with nonnegative coefficients. Maximum
likelihood estimation by use of polynomials with
nonnegative coefficients (absolutely monotonic)
polynomials) is quite different from maximum
likelihood estimation with polynomials with unre-
stricted coefficients. When the coefficients are un-
restricted, it makes no sense to consider polyno-
mials whose degree is greater than the number of
doses at which tests are conducted. When the coef-
ficients are constrained to be nonnegative, it is gen-
erally not possible to fit the data points exactly, no
matter how high the degree. In general increasing
the degree beyond a certain point can actually cause
the likelihood function to start decreasing. Unlike
the situation with unrestricted coefficients, in-
creasing the degree of absolutely monotonic
February 1978 149polynomials does not lead to complex curve shapes.
All that happens is that the high-dose part of the
curve hooks up more sharply while the low-dose
part of curve flattens out. The flatter the low-dose
part of the curve, the higher will be the predicted
dose corresponding to agiven level ofincreased risk
overbackground. Thus it is desirable not to exclude
high degree polynomials because doing this limits
artificially the extent to which data which are best
fit by very flat curves can be fit by curves of the
form (1). For this reason, we have developed the
theory needed for maximizing the likelihood func-
tion globally over all absolutely monotonic poly-
nomials, unrestricted as to degree. We have an effi-
cient method for calculating such estimates and
have obtained theorems describing their statistical
properties, such as asymptotic unbiasedness, strong
consistency, and asymptotic normality. In addi-
tion, we derive and calculate asymptotic (large-
sample) confidence intervals for the risk estimates
P(d) - P(O) and compare the calculated confidence
intervals with those obtained by computer simu-
lation. These confidence intervals are not the ordi-
nary binomial confidence limits at the test doses.
Rather they are obtained by means of a limit
theorem which we prove. Finally, we have de-
veloped a Monte Carlo goodness-of-fit test, which
involves comparing the actual data with sets ofarti-
ficial data simulated using the best estimate re-
sponse probabilities.
All of these calculations have been assembled
into one computer program which reads the
dichotomous data and calculates estimates of the
increased response probability over background,
confidence intervals for these estimates, and
goodness-of-fit-test results.
Our main conclusions are as follows: We can
easily specify hypothetical sets of dichotomous
dose-response data for which the best estimate
(maximum likelihood) low dose extrapolation ofthe
form of Eq. (1) is much closer to a probit extrapola-
*Probit curves vanish to infinite order at the origin in the
sense that d-k4)(a + b logd)- 0 as d - Ofor all k = 1,2,.
where 4) is the standard normal distribution function. Curves of
theform (1), beinganalytic, canonly vanish tofinite order. Thus,
given any curve ofthe form (1) and any probit curve, the probit
curve will eventually undershoot the curve of form (1) for d
sufficiently close to 0. However, as Table I shows, it is not
difficult to fit aprobit curve with a curve ofthe form (1) down to
doses corresponding to risk levels of about 10-7.
tWith the dimethylnitrosamine data it is possible to make the
linear coefficient q, vanish by excluding the response at the
highest dose tested. However, the goodness-of-fit, as measured
by our Monte Carlogoodness-of-fit test, was notrejectable at the
10%'o level with the highest dose included. For this reason, it did
not seem valid to exclude this response.
tion than to a linear extrapolation. Table I illus-
trates such data. We cite these results to dem-
onstrate that it is mathematically possible for risk
estimates based on Eq. (1) to be approximately the
same as risk estimates based on a probit model and
to differ by several orders of magnitude from risk
estimates based on a linear model.*
Table 1A. Hypothetical data for which the multistage model
approximates a probit curve.a
Dose Animals tested Animals with positive responses
0 1000 0
5 1000 0
10 1000 0
18 1000 1
30 1000 I 1
45 1000 42
60 1000 95
75 1000 161
aThe data are expected values computed from the probit curve
P(d) = 4) (-7.18 + 3.30 log d). This curve was also used to get
the probit low-dose extrapolation. The multistage and linear ex-
trapolations were obtained from the above hypothetical data by
maximum likelihood.
Table 1B. Low-dose extrapolations of data of Table 1A.
Dose d corresponding to given risk
Probit Multistage One-hit
Risk P(d) Model modela model
10-8 2.99 0.28 7.5 x 10-6
10-7 3.99 0.61 7.5 x 10-5
10-6 5.44 1.32 7.5 x 10-4
0-5 7.65 2.85 7.5 x 10-3
10-4 11.19 6.13 7.5 x 10-2
l0-3 17.35 13.22 0.75
10-2 29.56 28.52 7.55
10-' 61.24 62.42 79.14
aThe multistage model is the model based on Eq. (1).
In every set of actual data we have analyzed, the
linear term q1 is positive, and the best-estimate low-
dose extrapolation is much closer to a linear ex-
trapolation than a conservative Mantel-Bryan ex-
trapolation. We have analyzed data for vinyl
chloride, dieldrin, DDT, dimethylnitrosamine, and
ionizing radiation. Figures 1 and 2 illustrate the re-
sults for dieldrin.t In the range ofincreased response
between 10-5 and 10-8 the best-estimate dose-
response curve of the form of Eq. (1) for these
agents is typically one or two orders of magnitude
above a conservative Mantel-Bryan extrapolation.
Our results have implications which should be
considered by anyone who intends to design a
large-scale experiment to measure the shape of
dose-response curves for chemical carcinogens in
the very low-dose range. When both very flat
curves and gradually sloping (linearor nearly linear)
curves are considered together, it is extremely dif-
Environmental Health Perspectivesand the other in which there is an expected
background effect of about 10%.
Figure 3 shows low dose extrapolations for the
hypothetical data simulated as described in Table 2.
The expected response frequencies at the test doses
lie on the curve
P(d) = I - exp {-1.54 x 10-148 } (4)
One hundred sets of data were simulated bino-
mially for the eight doses shown in Table 2 with
1000 animals per dose. A maximum likelihood best
estimate dose-response curve of the form (1) was
calculated for each data set. At each ofeight levels
of increased risk over background P(d) - P(O) =
10-1, 10-2, ..., 10-8 the doses corresponding to
these risk levels were ranked in decreasing order.
The curve labeled "true dose response curve from
d
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FIGURE 1. Plot in which dieldrin data have been fitted by use of
Eq. (1). The dark dots indicate data points. The lines with
bars at each end represent 95% two-sided confidence inter-
vals for the risk at the test doses.
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FIGURE 2. Low dose estimates ofextra risk based upon the same
dieldrin data as Figure I by use of both expression (2) and
also the Mantel-Bryan approach.
ficult on mathematical grounds (even with nearly
perfect data) to reject the hypothesis that the dose-
response curve is nearly linear in the dose range
corresponding to increased risks over background
ofabout 10-6 or less. We demonstrate this with two
examples, one in which no background is present
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FIGURE 3. Best-estimate low-dose extrapolations for 100 sets of
simulated data. Test parameters are shown in Table 2.
which the test data were drawn" is the graph ofEq.
(4). The otherfour curves in Figure 3 were obtained
from the best-estimate low-dose extrapolations of
the 100 sets of simulated data. For example, the
curve labeled "10th lowest dose (out of 100) at each
risk level" is the curve constructed by connecting
the 10th lowest of the 100 best-estimate extrapo-
lated doses corresponding to a risk level of 10-1,
February 1978
Lowest dose
5-th Lowest dose
10th Lowest dose
151Table 2. Parameters for simulation study (low dose extrapolations
are shown in Fig. 3).a
Dose Animals tested Response probability used
0 1000 0.000
30 1000 0.010
35 1000 0.034
40 1000 0.0%
45 1000 0.228
50 1000 0.451
aThe response probabilities used lie on the curve: P(d) = I -
exp {- 1.54 x 10-'4d8}. One hundred sets of data were simu-
lated, and a best-estimate dose-response function ofthe form (1)
was calculated for each set. The doses corresponding to in-
creased risks of 10-1, 10-2, .. ., 10-8 were calculated foreach set
and each ofthese 8 sets of 100 doses was tabulated in decreasing
order.
with the 10th lowest at a risk level of 10-2, and so on
up to the 10th lowest at a risk level of 10-8. The
median curve was constructed by connecting the
median of the 100 best-estimate extrapolated doses
at each of the risk levels 10-1, . . ., 10-8.
The median curve is quite close to the true dose-
response curve (4), as it should be. However, the
striking result of this study is that the envelope
curve for the 10th lowest dose at each risk level is
almost perfectly linear at risk levels below 10-3.
This curve represents roughly an upper 90% confi-
dence interval on the true dose response curve. The
study shows that if a carcinogen with the highly
nonlinear (almost thresholdlike) curve (4) as its true
dose-response curve were to be tested in a perfectly
conducted large-scale (8000 animal) test with no
background effects present, using the doses shown
in Table 2, the test data would probably not reject
the hypothesis of linearity at the 10%o significance
level. In fact, the upper 90% confidence curve from
the test would probably not be very different from a
simple linear extrapolation ofthe expected response
frequency at the lowest positive dose tested.
When background is present, it is even more dif-
ficult to reject the hypothesis of near linearity in the
risk range of 10-6. Table 3 illustrates this dramati-
cally. By changing the outcomes of only 11 out of
8000 animals the best-estimate dose corresponding
to an increased risk of 10-6 over background
changes by more than three orders of magnitude.
Intuitively, what is happening here is that slight
changes in the experimental outcome involving a
few tenths of a percent of the animals at each dose
have an appreciable probability of occurring by
pure chance. Such changes can transform data
which are best fit by an extremely flat dose-
response curve into data which are best fit by a
dose-response curve withjust the slightest hint of a
positive linear term. When one extrapolates back to
risks of 10-6 or less, this small difference in slope is
magnified by several orders of magnitude.
Table 3A. Hypothetical data illustrating extreme sensitivity of
best-estimate extrapolation to minute changes in data when
background is present and true curve is flat.
Responses
Dose Animals tested Experiment 1 Experiment 2
0 1000 103 100
2 1000 99 99
15 1000 100 105
30 1000 109 112
35 1000 131 131
40 1000 187 187
45 1000 305 305
50 1000 506 506
aBest-estimate dose response curves: experiment 1: P(d) =
I - exp {- (0.105 + 1.1 x 10-15d7 + 1.5 x 1014d8)}; experiment 2:
P(d) = I - exp {- 0.106 + 1.6 x 10-4d' + 1.2 x 10-14d8 + 7.2 x
10-17d9)}.
Table 3B. Low dose extrapolations of data in Table 3A.
Dose
Increased risk P(d) - P(0) Experiment I Experiment 2
10-8 5.40 7.20 x 10-5
10-7 7.20 7.20 x 104
10-6 9.60 7.20 x 10-3
0-5 12.80 7.20 x 10-2
10-4 17.09 0.72
10-3 22.78 7.20
Sumrimary
An important tentative conclusion from our work
is that when dose-response curves that are ex-
tremely flat (probit-like) in the low-dose range are
comparedwith dose response curves that are nearly
linear in the low-dose range, the nearly linear
curves fit the data better for each ofthe four chemi-
cal compounds for which we have analyzed data. A
second conclusion is that ifanyone has data to sup-
port a very flatdose-response curve in the low-dose
range, this technique would permit one to infer the
flat shape from the data rather than having to as-
sume aflat curve shape, as one implicitly does when
using a probit technique. (However, as the
discussion above indicates, it is likely that any valid
upper 5 or 10% confidence limits on the risk esti-
mates from the data would not differ much from
linear extrapolations.) Finally, we believe that
simulation studies such as are discussed above
could be useful in designing animal carcinogenicity
tests and in helping to decide whether a given test
design has much chance ofaccomplishing its objec-
tives.
In our opinion, these results have implications
both for test design and for risk assessment. They
suggest that if the hypothesis of a nearly linear
dose-response curve in the low-dose range cannot
be ruled out by assumption, then it seems question-
able that it can be rejected by the data, even in cases
where it may be false.
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